Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Amarantus Bioscience Holdi AMBS
Posted On: 10/06/2014 7:48:46 AM
Post# of 30066
Posted By: Tanis2476
3:40 p.m. Est. MANF - A Novel Neurotrophic Factor for the Treatment of Retinal Disorders
Roman Urfer, Ph.D., Chief Development Officer, NeuroAssets Sarl
Mesencephalic astrocyte-derived neurotrophic factor is the prototype of an emerging family of neurotrophic factors with evolutionary highly conserved structure and function. MANF is expressed in response to cellular stress and during retinal development. MANF's activity in genetic and pharmacolocical models of retinal disorders will be presented.

3:55 Refreshment Break in the Exhibit Hall with Poster Viewing













(0)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site